Students
Teaching and Research Staff
Administrative and Services Staff
Intranet
Start
Get to know us
Strategic Areas
Equipment
Own Projects
Applicable Regulations
Services
Valorization
Regulation of R&D&I
Scientific Entrepreneurship
Administrative and Economic Management of the Transfer
Protocols, Agreements and Contracts
Transfer Programs
Protection
Protection of Research Results
How is protection provided at the ULL?
Patents and Utility Models
Intellectual Property and Software
Other forms of protection
Patent portfolio
Competitive Projects
Promotion and Management of National and Regional Projects
National and regional projects
European Projects Office
International projects
Euraxess
Own R&D Plan
Annual payment 2026
Calls for proposals
Agustín de Betancourt Program
R&D Offer
Science ULL
Contact
Skip to main content
University of La Laguna
EN
EN
ES
FR
Start
Get to know us
Strategic Areas
Equipment
Own Projects
Applicable Regulations
Services
Valorization
Regulation of R&D&I
Scientific Entrepreneurship
Administrative and Economic Management of the Transfer
Protocols, Agreements and Contracts
Transfer Programs
Protection
Protection of Research Results
How is protection provided at the ULL?
Patents and Utility Models
Intellectual Property and Software
Other forms of protection
Patent portfolio
Competitive Projects
Promotion and Management of National and Regional Projects
National and regional projects
European Projects Office
International projects
Euraxess
Own R&D Plan
Annual payment 2026
Calls for proposals
Agustín de Betancourt Program
R&D Offer
Science ULL
Contact
Agustín de Betancourt Program
Proof of concept for a non-invasive early diagnostic technology for Sporadic Alzheimer's Disease based on circulating exosomes
Proof of concept for a non-invasive early diagnostic technology for Sporadic Alzheimer's Disease based on circulating exosomes
Currently, there are no reliable methods for the early diagnosis of sporadic Alzheimer's disease (98% cases). However, we have previously identified more than 500 mRNAs differentially expressed in the human hippocampus, with the additional property that their products are exportable to exosomes. Given that the permeability of the blood-brain barrier is altered by the inflammatory state typical of the disease, our working hypothesis is that circulating exosomes in peripheral blood may carry a plethora of potential biomarkers of the disease. WORK PLAN: A population of 150 patients (age ≥64 years) will be stratified according to gender and medical condition (Healthy Controls, Mild Cognitive Impairment, Early-Stage Alzheimer's, Moderate Alzheimer's, Other Central Neurological/Psychiatric Disorders not related to Alzheimer's). In addition to a clinical and neurological history, patients will be studied using a battery of psychometric tests and magnetic resonance imaging (resting and functional MRI). Blood samples will be processed to obtain four sub-fractions of interest, on which high-resolution transcriptomic (RNA sequencing) and proteomic (LC-MS/MS/MS) analyses will be performed. EXPECTED RESULTS: The interdisciplinary approach, combining diverse sources of information (clinical, psychometric, MRI, analytical laboratory) using machine learning techniques, will allow the establishment of a set of biomarkers sufficiently sensitive and specific to discriminate the various stages of the disease, thus enabling the development of a diagnostic kit. IMPACT OF THE RESULTS: The availability of an early, non-invasive test for the diagnosis of sporadic Alzheimer's and its precursor forms would help mitigate a disease that affects 30 million people worldwide. This also represents a huge market, with enormous consequences for healthcare policies of both governments and affected individuals and their families.
ULL Team
Daniel Victor Guebel
Nestor Vicente Torres Darias
Project information
Area
Biotechnology, Biomedicine and Health
Principal Investigator
Daniel Victor Guebel
Company
Dr. Alayón Neurological Center SLP.
Call for applications
2018
Keywords
Alzheimer
Systems Biology
Early Diagnosis
Translational Medicine
All Agustín de Betancourt programs
We've detected you might be speaking a different language. Do you want to change to:
ES
ES
EN
FR
Change Language
Close and do not switch language
We've detected you might be speaking a different language. Do you want to change to:
ES
ES
EN
FR
Change Language